Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Fractures

  Free Subscription


Articles published in Osteoporos Int

Retrieve available abstracts of 502 articles:
HTML format
Text format



Single Articles


    June 2018
  1. GUPTA MJ, Shah S, Peterson S, Baim S, et al
    Rush Fracture Liaison Service for capturing "missed opportunities" to treat osteoporosis in patients with fragility fractures.
    Osteoporos Int. 2018 Jun 4. pii: 10.1007/s00198-018-4559.
    PubMed     Text format     Abstract available


  2. RIKKONEN T, Poole K, Sirola J, Sund R, et al
    Long-term effects of functional impairment on fracture risk and mortality in postmenopausal women.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4588.
    PubMed     Text format     Abstract available


  3. LOSADA E, Soldevila B, Ali MS, Martinez-Laguna D, et al
    Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2018 Jun 2. pii: 10.1007/s00198-018-4581.
    PubMed     Text format     Abstract available


  4. CARLSON BC, Robinson WA, Wanderman NR, Nassr AN, et al
    The American Orthopaedic Association's Own the Bone(R) database: a national quality improvement project for the treatment of bone health in fragility fracture patients.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4585.
    PubMed     Text format     Abstract available


  5. JAIN RK, Vokes T
    Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005-2008.
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4584.
    PubMed     Text format     Abstract available


  6. KIM SJ, Park HS, Lee DW, Lee JW, et al
    Is calcium phosphate augmentation a viable option for osteoporotic hip fractures?
    Osteoporos Int. 2018 Jun 1. pii: 10.1007/s00198-018-4572.
    PubMed     Text format     Abstract available


    May 2018
  7. UGLAND TO, Haugeberg G, Svenningsen S, Ugland SH, et al
    Biomarkers of muscle damage increased in anterolateral compared to direct lateral approach to the hip in hemiarthroplasty: no correlation with clinical outcome : Short-term analysis of secondary outcomes from a randomized clinical trial in patients wi
    Osteoporos Int. 2018 May 22. pii: 10.1007/s00198-018-4557.
    PubMed     Text format     Abstract available


  8. VOETEN SC, Krijnen P, Voeten DM, Hegeman JH, et al
    Quality indicators for hip fracture care, a systematic review.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4558.
    PubMed     Text format     Abstract available


  9. GENEST F, Seefried L
    Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4552.
    PubMed     Text format     Abstract available


  10. SU Y, Lai FTT, Yip BHK, Leung JCS, et al
    Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
    Osteoporos Int. 2018 May 17. pii: 10.1007/s00198-018-4543.
    PubMed     Text format     Abstract available


  11. NGUYEN ET, Posas-Mendoza T, Siu AM, Ahn HJ, et al
    Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
    Osteoporos Int. 2018 May 9. pii: 10.1007/s00198-018-4553.
    PubMed     Text format     Abstract available


    April 2018
  12. INDERJEETH CA, Raymond WD, Briggs AM, Geelhoed E, et al
    Implementation of the Western Australian Osteoporosis Model of Care: a fracture liaison service utilising emergency department information systems to identify patients with fragility fracture to improve current practice and reduce re-fracture rates: a
    Osteoporos Int. 2018 Apr 27. pii: 10.1007/s00198-018-4526.
    PubMed     Text format     Abstract available


  13. DELL R, Greene D
    A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
    Osteoporos Int. 2018 Apr 19. pii: 10.1007/s00198-018-4506.
    PubMed     Text format     Abstract available


  14. BENETOU V, Orfanos P, Feskanich D, Michaelsson K, et al
    Mediterranean diet and hip fracture incidence among older adults: the CHANCES project.
    Osteoporos Int. 2018 Apr 14. pii: 10.1007/s00198-018-4517.
    PubMed     Text format     Abstract available


  15. YIN P, Lv H, Li Y, Meng Y, et al
    Hip fracture patients who experience a greater fluctuation in RDW during hospital course are at heightened risk for all-cause mortality: a prospective study with 2-year follow-up.
    Osteoporos Int. 2018 Apr 14. pii: 10.1007/s00198-018-4516.
    PubMed     Text format     Abstract available


  16. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-017-4373.
    PubMed     Text format     Abstract available


  17. CLARK EM, Gooberman-Hill R, Peters TJ
    Correction to: Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2018 Apr 12. pii: 10.1007/s00198-018-4495.
    PubMed     Text format     Abstract available


  18. WANG MQ, Youssef T, Smerdely P
    Incidence and outcomes of humeral fractures in the older person.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4500.
    PubMed     Text format     Abstract available


  19. ZHU JJ, Mahendran D, Lee MH, Seah J, et al
    Systemic mastocytosis identified in two women developing fragility fractures during lactation.
    Osteoporos Int. 2018 Apr 4. pii: 10.1007/s00198-018-4498.
    PubMed     Text format     Abstract available


    March 2018
  20. XIAO X, Xu Y, Wu Q
    Thiazide diuretic usage and risk of fracture: a meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 25. pii: 10.1007/s00198-018-4486.
    PubMed     Text format     Abstract available


  21. PASKINS Z, Whittle R, Abdul Sultan A, Muller S, et al
    Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study.
    Osteoporos Int. 2018 Mar 24. pii: 10.1007/s00198-018-4491.
    PubMed     Text format     Abstract available


  22. UNGPRASERT P, Crowson CS, Matteson EL
    Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013-supplementary presentation.
    Osteoporos Int. 2018 Mar 22. pii: 10.1007/s00198-017-4074.
    PubMed     Text format     Abstract available


  23. GRAUMAM RQ, Pinheiro MM, Nery LE, Castro CHM, et al
    Increased rate of osteoporosis, low lean mass, and fragility fractures in COPD patients: association with disease severity.
    Osteoporos Int. 2018 Mar 21. pii: 10.1007/s00198-018-4483.
    PubMed     Text format     Abstract available


  24. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    PubMed     Text format     Abstract available


  25. JIN S, Hsieh E, Peng L, Yu C, et al
    Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2018 Mar 15. pii: 10.1007/s00198-018-4473.
    PubMed     Text format     Abstract available


  26. WU Q, Liu B, Tonmoy S
    Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.
    Osteoporos Int. 2018 Mar 12. pii: 10.1007/s00198-018-4420.
    PubMed     Text format     Abstract available


  27. WU CH, Chen CH, Chen PH, Yang JJ, et al
    Identifying characteristics of an effective fracture liaison service: systematic literature review.
    Osteoporos Int. 2018 Mar 10. pii: 10.1007/s00198-017-4370.
    PubMed     Text format     Abstract available


  28. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Naboulsi H, et al
    Correction to: Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.
    Osteoporos Int. 2018 Mar 5. pii: 10.1007/s00198-018-4432.
    PubMed     Text format     Abstract available


  29. BYBERG L, Michaelsson K
    Comments on Feskanich et al.: Milk and other dairy foods and risk of hip fracture in men and women.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4397.
    PubMed     Text format    


  30. ZHANG Y, Hao Q, Ge M, Dong B, et al
    Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies.
    Osteoporos Int. 2018 Mar 2. pii: 10.1007/s00198-018-4429.
    PubMed     Text format     Abstract available


    February 2018
  31. PACCOU J, D'Angelo S, Rhodes A, Curtis EM, et al
    Prior fragility fracture and risk of incident ischaemic cardiovascular events: results from UK Biobank.
    Osteoporos Int. 2018 Feb 26. pii: 10.1007/s00198-018-4426.
    PubMed     Text format     Abstract available


  32. UEI H, Tokuhashi Y, Maseda M, Nakahashi M, et al
    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: a case report.
    Osteoporos Int. 2018 Feb 23. pii: 10.1007/s00198-018-4425.
    PubMed     Text format     Abstract available


  33. GUIRANT L, Carlos F, Curiel D, Kanis JA, et al
    Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4389.
    PubMed     Text format     Abstract available


  34. KUIPER BW, Graybill S, Tate JM, Kaufman N, et al
    After the fall: improving osteoporosis treatment following hip fracture.
    Osteoporos Int. 2018 Feb 20. pii: 10.1007/s00198-018-4416.
    PubMed     Text format     Abstract available


  35. LEE CK, Choi SK, Shin DA, Yi S, et al
    Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4409.
    PubMed     Text format     Abstract available


  36. WU CH, Kao IJ, Hung WC, Lin SC, et al
    Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
    Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4411.
    PubMed     Text format     Abstract available


  37. BINKLEY N, Krueger D, de Papp AE
    Multiple vertebral fractures following osteoporosis treatment discontinuation: a case-report after long-term Odanacatib.
    Osteoporos Int. 2018 Feb 18. pii: 10.1007/s00198-018-4385.
    PubMed     Text format     Abstract available


  38. GHEORGHITA A, Webster F, Thielke S, Sale JEM, et al
    Long-term experiences of pain after a fragility fracture.
    Osteoporos Int. 2018 Feb 17. pii: 10.1007/s00198-018-4399.
    PubMed     Text format     Abstract available


  39. ROUX S, Gaboury I, Gionet-Landry N, Garant MP, et al
    Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
    Osteoporos Int. 2018 Feb 14. pii: 10.1007/s00198-017-4374.
    PubMed     Text format     Abstract available


  40. GREENSPAN SL, Singer A, Vujevich K, Marchand B, et al
    Implementing a fracture liaison service open model of care utilizing a cloud-based tool.
    Osteoporos Int. 2018 Feb 10. pii: 10.1007/s00198-017-4371.
    PubMed     Text format     Abstract available


  41. PRZEDLACKI J, Buczynska-Chyl J, Kozminski P, Niemczyk E, et al
    The utility of FRAX(R) in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.
    Osteoporos Int. 2018 Feb 6. pii: 10.1007/s00198-018-4406.
    PubMed     Text format     Abstract available


  42. BERGMAN J, Nordstrom A, Nordstrom P
    Bisphosphonate use after clinical fracture and risk of new fracture.
    Osteoporos Int. 2018 Feb 3. pii: 10.1007/s00198-017-4367.
    PubMed     Text format     Abstract available


    January 2018
  43. KLINGBERG S, Mehlig K, Sundh V, Heitmann BL, et al
    Lower risk of hip fractures among Swedish women with large hips?
    Osteoporos Int. 2018 Jan 27. pii: 10.1007/s00198-017-4363.
    PubMed     Text format     Abstract available


  44. WRIGHT NC, Hooker ER, Nielson CM, Ensrud KE, et al
    The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2018 Jan 17. pii: 10.1007/s00198-017-4349.
    PubMed     Text format     Abstract available


  45. JOHANSSON H, Hongslo Vala C, Oden A, Lorentzon M, et al
    Low risk for hip fracture and high risk for hip arthroplasty due to osteoarthritis among Swedish farmers.
    Osteoporos Int. 2018 Jan 12. pii: 10.1007/s00198-017-4355.
    PubMed     Text format     Abstract available


    December 2017
  46. CHANG Y-, Huang C-, Hwang J-, Kuo J-, et al
    Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.
    Osteoporos Int. 2017 Dec 28. pii: 10.1007/s00198-017-4347.
    PubMed     Text format     Abstract available


  47. MICHAEL LEWIECKI E, Wright NC, Curtis JR, Siris E, et al
    Hip fracture trends in the United States, 2002 to 2015.
    Osteoporos Int. 2017 Dec 27. pii: 10.1007/s00198-017-4345.
    PubMed     Text format     Abstract available


  48. TAMIMI I, Nicolau B, Eimar H, Arekunnath Madathil S, et al
    Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study.
    Osteoporos Int. 2017 Dec 20. pii: 10.1007/s00198-017-4346.
    PubMed     Text format     Abstract available


  49. VAN DEN BERG P, van Haard PMM, van der Veer E, Geusens PP, et al
    A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4340.
    PubMed     Text format     Abstract available


  50. LUTHMAN S, Widen J, Borgstrom F
    Appropriateness criteria for treatment of osteoporotic vertebral compression fractures.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4348.
    PubMed     Text format     Abstract available


  51. NURMI-LUTHJE I, Tiihonen R, Paattiniemi EL, Naboulsi H, et al
    Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.
    Osteoporos Int. 2017 Dec 19. pii: 10.1007/s00198-017-4344.
    PubMed     Text format     Abstract available


  52. NIIMI R, Kono T, Nishihara A, Hasegawa M, et al
    Rebound-associated vertebral fractures after discontinuation of denosumab for the treatment of maxillitis.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4334.
    PubMed     Text format     Abstract available


  53. SVEDBOM A, Borgstom F, Hernlund E, Strom O, et al
    Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.
    Osteoporos Int. 2017 Dec 11. pii: 10.1007/s00198-017-4317.
    PubMed     Text format     Abstract available


  54. WATANABE R, Shiraki M, Saito M, Okazaki R, et al
    Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women.
    Osteoporos Int. 2017 Dec 7. pii: 10.1007/s00198-017-4337.
    PubMed     Text format     Abstract available


  55. SHEEHAN KJ, Filliter C, Sobolev B, Levy AR, et al
    Time to surgery after hip fracture across Canada by timing of admission.
    Osteoporos Int. 2017 Dec 6. pii: 10.1007/s00198-017-4333.
    PubMed     Text format     Abstract available


    November 2017
  56. BREDEMEIER M
    Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4263.
    PubMed     Text format    


  57. PACCOU J, Cortet B
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier.
    Osteoporos Int. 2017 Nov 27. pii: 10.1007/s00198-017-4320.
    PubMed     Text format    


  58. VRANKEN L, Wyers CE, Van der Velde RY, Janzing HM, et al
    Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service.
    Osteoporos Int. 2017 Nov 23. pii: 10.1007/s00198-017-4290.
    PubMed     Text format     Abstract available


  59. WATANABE R, Tai N, Hirano J, Ban Y, et al
    Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4314.
    PubMed     Text format     Abstract available


  60. YANG L, Parimi N, Orwoll ES, Black DM, et al
    Association of incident hip fracture with the estimated femoral strength by finite element analysis of DXA scans in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2017 Nov 22. doi: 10.1007/s00198-017-4319.
    PubMed     Text format     Abstract available


  61. CHRISTOFFERSEN T, Emaus N, Dennison E, Furberg AS, et al
    The association between childhood fractures and adolescence bone outcomes: a population-based study, the Tromso Study, Fit Futures.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4300.
    PubMed     Text format     Abstract available


  62. ROZENTAL TD, Johannesdottir F, Walley KC, Bouxsein ML, et al
    Correction to: Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures.
    Osteoporos Int. 2017 Nov 16. doi: 10.1007/s00198-017-4311.
    PubMed     Text format     Abstract available


  63. JOHANSSON L, Sundh D, Nilsson M, Mellstrom D, et al
    Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.
    Osteoporos Int. 2017 Nov 15. doi: 10.1007/s00198-017-4296.
    PubMed     Text format     Abstract available


  64. SCHONENBERG D, Guggenberger R, Frey D, Pape HC, et al
    CT-based evaluation of volumetric bone density in fragility fractures of the pelvis-a matched case-control analysis.
    Osteoporos Int. 2017 Nov 13. doi: 10.1007/s00198-017-4307.
    PubMed     Text format     Abstract available


  65. SUN Y, Liu C, Bo Y, You J, et al
    Dietary vitamin C intake and the risk of hip fracture: a dose-response meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4284.
    PubMed     Text format     Abstract available


  66. ROZENTAL TD, Johannesdottir F, Kempland KC, Bouxsein ML, et al
    Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4293.
    PubMed     Text format     Abstract available


  67. AL-SARI UA, Tobias JH, Clark EM
    Self-reported everyday physical activities in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4287.
    PubMed     Text format     Abstract available


  68. KAZE AD, Rosen HN, Paik JM
    A meta-analysis of the association between body mass index and risk of vertebral fracture.
    Osteoporos Int. 2017 Nov 3. doi: 10.1007/s00198-017-4294.
    PubMed     Text format     Abstract available


    October 2017
  69. SCHOUSBOE JT, Vo TN, Langsetmo L, Taylor BC, et al
    Predictors of change of trabecular bone score (TBS) in older men: results from the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2017 Oct 31. doi: 10.1007/s00198-017-4273.
    PubMed     Text format     Abstract available


  70. GREENSPAN SL, Vujevich K, Britton C, Herradura A, et al
    Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
    Osteoporos Int. 2017 Oct 30. doi: 10.1007/s00198-017-4286.
    PubMed     Text format     Abstract available


  71. FESKANICH D, Meyer HE, Fung TT, Bischoff-Ferrari HA, et al
    Milk and other dairy foods and risk of hip fracture in men and women.
    Osteoporos Int. 2017 Oct 27. doi: 10.1007/s00198-017-4285.
    PubMed     Text format     Abstract available


  72. RATHBUN AM, Magaziner J, Shardell MD, Yerges-Armstrong LM, et al
    Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4280.
    PubMed     Text format     Abstract available


  73. SU Y, Leung J, Kwok T
    The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2017 Oct 24. doi: 10.1007/s00198-017-4277.
    PubMed     Text format     Abstract available


  74. LIN SM, Yang SH, Liang CC, Huang HK, et al
    Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Osteoporos Int. 2017 Oct 14. doi: 10.1007/s00198-017-4262.
    PubMed     Text format     Abstract available


  75. BINKLEY N, Besuyen R, Fuerst T, Skillern L, et al
    Is drug-induced bone loss acceptable in premenopausal women? A practical fracture risk modeling exercise.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4258.
    PubMed     Text format     Abstract available


  76. VERONESE N, Stubbs B, Koyanagi A, Hebert JR, et al
    Pro-inflammatory dietary pattern is associated with fractures in women: an eight-year longitudinal cohort study.
    Osteoporos Int. 2017 Oct 10. doi: 10.1007/s00198-017-4251.
    PubMed     Text format     Abstract available


  77. RODRIGUEZ AJ, Scott D, Ebeling PR
    Comments on Li et al.: Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4246.
    PubMed     Text format    


  78. LI C, Wang Q
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men: response to comments by Rodriguez et al.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4245.
    PubMed     Text format    


  79. YANG S, Leslie WD, Luo Y, Goertzen AL, et al
    Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
    Osteoporos Int. 2017 Oct 6. doi: 10.1007/s00198-017-4232.
    PubMed     Text format     Abstract available


  80. VOGIATZI MG, Li D, Tian L, Garifallou JP, et al
    A novel dominant COL11A1 mutation in a child with Stickler syndrome type II is associated with recurrent fractures.
    Osteoporos Int. 2017 Oct 3. doi: 10.1007/s00198-017-4229.
    PubMed     Text format     Abstract available


    September 2017
  81. FREDERIKSEN A, Abrahamsen B, Johansen PB, Sorensen HA, et al
    Danish, national cross-sectional observational study on the prevalence of prior major osteoporotic fractures in adults presenting with hip fracture-limitations and scope for fracture liaison services in prevention of hip fracture.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4247.
    PubMed     Text format     Abstract available


  82. BHIMJIYANI A, Neuburger J, Jones T, Ben-Shlomo Y, et al
    The effect of social deprivation on hip fracture incidence in England has not changed over 14 years: an analysis of the English Hospital Episodes Statistics (2001-2015).
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4238.
    PubMed     Text format     Abstract available


  83. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2017 Sep 30. doi: 10.1007/s00198-017-4239.
    PubMed     Text format     Abstract available


  84. HOLLOWAY KL, Mohebbi M, Betson AG, Hans D, et al
    Prediction of major osteoporotic and hip fractures in Australian men using FRAX scores adjusted with trabecular bone score.
    Osteoporos Int. 2017 Sep 23. doi: 10.1007/s00198-017-4226.
    PubMed     Text format     Abstract available


  85. STENEVI LUNDGREN S, Rosengren BE, Dencker M, Nilsson JA, et al
    Low physical activity is related to clustering of risk factors for fracture-a 2-year prospective study in children.
    Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4203.
    PubMed     Text format     Abstract available


  86. ANSARI H, Beaton DE, Sujic R, Rotondi NK, et al
    Equal treatment: no evidence of gender inequity in osteoporosis management in a coordinator-based fragility fracture screening program.
    Osteoporos Int. 2017 Sep 10. doi: 10.1007/s00198-017-4206.
    PubMed     Text format     Abstract available


  87. LAROCHE M, Talibart M, Cormier C, Roux C, et al
    Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature.
    Osteoporos Int. 2017 Sep 6. doi: 10.1007/s00198-017-4165.
    PubMed     Text format     Abstract available


  88. KAEWBOONCHOO O, Sung FC, Lin CL, Hsu HC, et al
    Hip fracture risk in patients with burn injury: a retrospective cohort study in Taiwan.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4209.
    PubMed     Text format     Abstract available


  89. MIGNOT MA, Taisne N, Legroux I, Cortet B, et al
    Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4215.
    PubMed     Text format     Abstract available


  90. PEDERSEN AB, Ehrenstein V, Szepligeti SK, Sorensen HT, et al
    Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity.
    Osteoporos Int. 2017 Sep 5. doi: 10.1007/s00198-017-4213.
    PubMed     Text format     Abstract available


    August 2017
  91. LITWIC AE, Compston JE, Wyman A, Siris ES, et al
    Self-perception of fracture risk: what can it tell us?
    Osteoporos Int. 2017 Aug 31. doi: 10.1007/s00198-017-4200.
    PubMed     Text format     Abstract available


  92. LIU YY, Xue FS, Li HX
    Assessing impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2017 Aug 28. doi: 10.1007/s00198-017-4194.
    PubMed     Text format    


  93. MALGO F, Hamdy NAT, Ticheler CHJM, Smit F, et al
    Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis.
    Osteoporos Int. 2017 Aug 25. doi: 10.1007/s00198-017-4137.
    PubMed     Text format     Abstract available


  94. LIU FL, Lin CS, Yeh CC, Shih CC, et al
    Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies.
    Osteoporos Int. 2017 Aug 18. doi: 10.1007/s00198-017-4192.
    PubMed     Text format     Abstract available


  95. LIU GY, Cao GL, Tian FM, Song HP, et al
    Parathyroid hormone (1-34) promotes fracture healing in ovariectomized rats with type 2 diabetes mellitus.
    Osteoporos Int. 2017 Aug 14. doi: 10.1007/s00198-017-4148.
    PubMed     Text format     Abstract available


  96. JIA P, Bao L, Chen H, Yuan J, et al
    Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies.
    Osteoporos Int. 2017 Aug 9. doi: 10.1007/s00198-017-4183.
    PubMed     Text format     Abstract available


  97. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Erratum to: Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Aug 7. doi: 10.1007/s00198-017-4161.
    PubMed     Text format    


  98. ZHAO Y, Wang J, Yao W, Cai Q, et al
    Interventions for humeral shaft fractures: mixed treatment comparisons of clinical trials.
    Osteoporos Int. 2017 Aug 5. doi: 10.1007/s00198-017-4174.
    PubMed     Text format     Abstract available


  99. SCHNEIDER PS, Wall M, Brown JP, Cheung AM, et al
    Atypical femur fractures: a survey of current practices in orthopedic surgery.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4155.
    PubMed     Text format     Abstract available


  100. SAITO T, Sterbenz JM, Malay S, Zhong L, et al
    Effectiveness of anti-osteoporotic drugs to prevent secondary fragility fractures: systematic review and meta-analysis.
    Osteoporos Int. 2017 Aug 2. doi: 10.1007/s00198-017-4175.
    PubMed     Text format     Abstract available


    July 2017
  101. WILLIAMS ST, Lawrence PT, Miller KL, Crook JL, et al
    A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
    Osteoporos Int. 2017 Jul 30. doi: 10.1007/s00198-017-4172.
    PubMed     Text format     Abstract available


  102. KOH JH, Myong JP, Yoo J, Lim YW, et al
    Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Osteoporos Int. 2017 Jul 27. doi: 10.1007/s00198-017-4169.
    PubMed     Text format     Abstract available


  103. WILLIAMSON S, Landeiro F, McConnell T, Fulford-Smith L, et al
    Costs of fragility hip fractures globally: a systematic review and meta-regression analysis.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4153.
    PubMed     Text format     Abstract available


  104. VAN DER VELDE RY, Bours SPG, Wyers CE, Lems WF, et al
    Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.
    Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147.
    PubMed     Text format     Abstract available


  105. MARTINEZ-LAGUNA D, Nogues X, Abrahamsen B, Reyes C, et al
    Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study.
    Osteoporos Int. 2017 Jul 25. doi: 10.1007/s00198-017-4096.
    PubMed     Text format     Abstract available


  106. NASIRI SARVI M, Luo Y
    Sideways fall-induced impact force and its effect on hip fracture risk: a review.
    Osteoporos Int. 2017 Jul 20. doi: 10.1007/s00198-017-4138.
    PubMed     Text format     Abstract available


  107. DRIESSEN JHM, Knapen LM, Geusens PPMM, van den Bergh JPW, et al
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4120.
    PubMed     Text format    


  108. KOSTEV K, Dombrowski S
    Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: response to Driessen et al.
    Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139.
    PubMed     Text format    


  109. LI X, Gong X, Jiang W
    Abdominal obesity and risk of hip fracture: a meta-analysis of prospective studies.
    Osteoporos Int. 2017 Jul 12. doi: 10.1007/s00198-017-4142.
    PubMed     Text format     Abstract available


  110. COSMAN F
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014---supplementary presentation.
    Osteoporos Int. 2017 Jul 10. doi: 10.1007/s00198-017-3999.
    PubMed     Text format     Abstract available


  111. HANUSCH BC, Tuck SP, McNally RJQ, Wu JJ, et al
    Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?
    Osteoporos Int. 2017 Jul 6. doi: 10.1007/s00198-017-4122.
    PubMed     Text format     Abstract available


    June 2017
  112. MENDIS AS, Ganda K, Seibel MJ
    Barriers to secondary fracture prevention in primary care.
    Osteoporos Int. 2017 Jun 29. doi: 10.1007/s00198-017-4131.
    PubMed     Text format     Abstract available


  113. FISCHER S, Kapinos KA, Mulcahy A, Pinto L, et al
    Estimating the long-term functional burden of osteoporosis-related fractures.
    Osteoporos Int. 2017 Jun 24. doi: 10.1007/s00198-017-4110.
    PubMed     Text format     Abstract available


  114. OSHAGBEMI OA, Driessen JHM, Pieffers A, Wouters EFM, et al
    Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Osteoporos Int. 2017 Jun 21. doi: 10.1007/s00198-017-4115.
    PubMed     Text format     Abstract available


  115. LEE YK, Kim TY, Ha YC, Song SH, et al
    Atypical subtrochanteric fractures in Korean hip fracture study.
    Osteoporos Int. 2017 Jun 14. doi: 10.1007/s00198-017-4112.
    PubMed     Text format     Abstract available


  116. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4091.
    PubMed     Text format     Abstract available


  117. WEYCKER D, Edelsberg J, Barron R, Atwood M, et al
    Predictors of near-term fracture in osteoporotic women aged >/=65 years, based on data from the study of osteoporotic fractures.
    Osteoporos Int. 2017 Jun 7. doi: 10.1007/s00198-017-4103.
    PubMed     Text format     Abstract available


  118. LEHMANN T, Aeberli D
    Possible protective effect of switching from denosumab to zoledronic acid on vertebral fractures.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4108.
    PubMed     Text format    


  119. SVENSSON HK, Olsson L-, Hansson T, Karlsson J, et al
    The effects of person-centered or other supportive interventions in older women with osteoporotic vertebral compression fractures-a systematic review of the literature.
    Osteoporos Int. 2017 Jun 6. doi: 10.1007/s00198-017-4099.
    PubMed     Text format     Abstract available


  120. SAHNI S, Soedamah-Muthu SS, Weaver CM
    Higher milk intake increases fracture risk: confounding or true association?
    Osteoporos Int. 2017 Jun 1. doi: 10.1007/s00198-017-4088.
    PubMed     Text format    


    May 2017
  121. CUI L, Chen L, Xia W, Jiang Y, et al
    Vertebral fracture in postmenopausal Chinese women: a population-based study.
    Osteoporos Int. 2017 May 30. doi: 10.1007/s00198-017-4085.
    PubMed     Text format     Abstract available


  122. DONZELLI A, Battaggia A, Schivalocchi A
    Statin use does not protect from fractures: the healthy adherer effect is a plausible explanation in observational studies.
    Osteoporos Int. 2017 May 29. doi: 10.1007/s00198-017-4069.
    PubMed     Text format    


  123. KESHISHIAN A, Boytsov N, Burge R, Krohn K, et al
    Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4072.
    PubMed     Text format     Abstract available


  124. FRAENKEL M, Yitshak-Sade M, Beacher L, Carmeli M, et al
    Is the association between hip fractures and seasonality modified by influenza vaccination? An ecological study.
    Osteoporos Int. 2017 May 23. doi: 10.1007/s00198-017-4077.
    PubMed     Text format     Abstract available


  125. VALA CH, Sundh V, Mellstrom D
    Increased risk of hip fracture among spouses-evidence of a homogamy effect: response to comments by Minkov.
    Osteoporos Int. 2017 May 22. doi: 10.1007/s00198-017-4092.
    PubMed     Text format    


  126. MINKOV D
    Hip fractures or femoral fractures?
    Osteoporos Int. 2017 May 22. doi: 10.1007/s00198-017-3942.
    PubMed     Text format    


  127. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Response to Sabour: Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders: methodological issues.
    Osteoporos Int. 2017 May 15. doi: 10.1007/s00198-017-4056.
    PubMed     Text format    


  128. SABOUR S
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders: methodological issues.
    Osteoporos Int. 2017 May 13. doi: 10.1007/s00198-017-3990.
    PubMed     Text format    


  129. GULIN T, Kruljac I, Kirigin Bilos LS, Gulin M, et al
    The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.
    Osteoporos Int. 2017 May 13. doi: 10.1007/s00198-017-4068.
    PubMed     Text format     Abstract available


  130. YIN P, Lv H, Li Y, Meng Y, et al
    The association between serum uric acid level and the risk of fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4059.
    PubMed     Text format     Abstract available


  131. LIN YC, Huang TS, Wu JS, Cheung YC, et al
    Are bilateral decubitus views necessary in assessing for vertebral compression fractures using DXA vertebral fracture assessment?
    Osteoporos Int. 2017 May 9. doi: 10.1007/s00198-017-4040.
    PubMed     Text format     Abstract available


  132. BOGL HP, Aspenberg P, Schilcher J
    Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.
    Osteoporos Int. 2017 May 4. doi: 10.1007/s00198-017-4058.
    PubMed     Text format     Abstract available


  133. MALGO F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site.
    Osteoporos Int. 2017 May 2. doi: 10.1007/s00198-017-4054.
    PubMed     Text format     Abstract available


  134. MCCLUNG MR, Wagman RB, Miller PD, Wang A, et al
    Observations following discontinuation of long-term denosumab therapy.
    Osteoporos Int. 2017;28:1723-1732.
    PubMed     Text format     Abstract available


    April 2017
  135. DOMBROWSKI S, Kostev K, Jacob L
    Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-A retrospective analysis of real-world data.
    Osteoporos Int. 2017 Apr 29. doi: 10.1007/s00198-017-4051.
    PubMed     Text format     Abstract available


  136. KANIS JA, Cooper C, Rizzoli R, Abrahamsen B, et al
    Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting.
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4009.
    PubMed     Text format     Abstract available


  137. MCCLOSKEY EV
    Identification of vertebral fractures: a moderately severe solution?
    Osteoporos Int. 2017 Apr 27. doi: 10.1007/s00198-017-4042.
    PubMed     Text format    


  138. BERRY SD, Zullo AR, McConeghy K, Lee Y, et al
    Defining hip fracture with claims data: outpatient and provider claims matter.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4008.
    PubMed     Text format     Abstract available


  139. LI C, Zeng Y, Tao L, Liu S, et al
    Meta-analysis of hypertension and osteoporotic fracture risk in women and men.
    Osteoporos Int. 2017 Apr 26. doi: 10.1007/s00198-017-4050.
    PubMed     Text format     Abstract available


  140. CLARK EM, Cummings SR, Schousboe JT
    Spinal radiographs in those with back pain-when are they appropriate to diagnose vertebral fractures?
    Osteoporos Int. 2017 Apr 25. doi: 10.1007/s00198-017-4052.
    PubMed     Text format     Abstract available


  141. MOBERG L, Nilsson PM, Samsioe G, Sallsten G, et al
    Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmo Diet and Cancer Study.
    Osteoporos Int. 2017 Apr 21. doi: 10.1007/s00198-017-4047.
    PubMed     Text format     Abstract available


  142. DOMBROWSKI S, Jacob L, Hadji P, Kostev K, et al
    Oral contraceptive use and fracture risk-a retrospective study of 12,970 women in the UK.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4036.
    PubMed     Text format     Abstract available


  143. SATO H, Kondo N, Nakatsue T, Wada Y, et al
    High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2017 Apr 13. doi: 10.1007/s00198-017-4038.
    PubMed     Text format     Abstract available


  144. YAN J, Liu HJ, Li H, Chen L, et al
    Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women.
    Osteoporos Int. 2017 Apr 5. doi: 10.1007/s00198-017-4034.
    PubMed     Text format     Abstract available


  145. BARDAI G, Ward LM, Trejo P, Moffatt P, et al
    Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.
    Osteoporos Int. 2017 Apr 4. doi: 10.1007/s00198-017-4031.
    PubMed     Text format     Abstract available


  146. HUNG YC, Lin CC, Chen HJ, Chang MP, et al
    Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study.
    Osteoporos Int. 2017 Apr 3. doi: 10.1007/s00198-017-4021.
    PubMed     Text format     Abstract available


    March 2017
  147. PETIT M-, Bryere J, Maravic M, Pallaro F, et al
    Hip fracture incidence and social deprivation: results from a French ecological study.
    Osteoporos Int. 2017 Mar 23. doi: 10.1007/s00198-017-3998.
    PubMed     Text format     Abstract available


  148. CHEN YY, Feng JY, Ting WY, Yen YF, et al
    Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
    Osteoporos Int. 2017 Mar 22. doi: 10.1007/s00198-017-3939.
    PubMed     Text format     Abstract available


  149. THOMPSON MJ, Aitken DA, Otahal P, Cicolini J, et al
    The relationship between cumulative lifetime ultraviolet radiation exposure, bone mineral density, falls risk and fractures in older adults.
    Osteoporos Int. 2017 Mar 20. doi: 10.1007/s00198-017-4001.
    PubMed     Text format     Abstract available


  150. MOHD-TAHIR NA, Li SC
    Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3985.
    PubMed     Text format     Abstract available


  151. ASADIPOOYA K, Graves L, Greene LW
    Transient osteoporosis of the hip: review of the literature.
    Osteoporos Int. 2017 Mar 17. doi: 10.1007/s00198-017-3952.
    PubMed     Text format     Abstract available


  152. MAHARLOUEI N, Atefi S, Namazi H, Kazemifar S, et al
    The incidence of hip fracture in Shiraz, Iran: a promising rate comparing to previous studies.
    Osteoporos Int. 2017 Mar 16. doi: 10.1007/s00198-017-3983.
    PubMed     Text format     Abstract available


  153. MAJUMDAR SR, Lier DA, Hanley DA, Juby AG, et al
    Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
    Osteoporos Int. 2017 Mar 9. doi: 10.1007/s00198-017-3986.
    PubMed     Text format     Abstract available


  154. IMAI T, Tanaka S, Kawakami K, Miyazaki T, et al
    Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3966.
    PubMed     Text format     Abstract available


  155. KERR C, Bottomley C, Shingler S, Giangregorio L, et al
    The importance of physical function to people with osteoporosis.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3911.
    PubMed     Text format     Abstract available


  156. MORIWAKI K, Mouri M, Hagino H
    Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.
    Osteoporos Int. 2017 Mar 6. doi: 10.1007/s00198-017-3973.
    PubMed     Text format     Abstract available


  157. WEI Y, Tian W, Zhang GL, Lv YW, et al
    Thoracolumbar kyphosis is associated with compressive vertebral fracture in postmenopausal women.
    Osteoporos Int. 2017 Mar 1. doi: 10.1007/s00198-017-3971.
    PubMed     Text format     Abstract available


    February 2017
  158. MERLE B, Chapurlat R, Vignot E, Thomas T, et al
    Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
    Osteoporos Int. 2017 Feb 28. doi: 10.1007/s00198-017-3953.
    PubMed     Text format     Abstract available


  159. NARDONE V, Tini P, Carbone SF, Grassi A, et al
    Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3968.
    PubMed     Text format     Abstract available


  160. TAMAKI J, Iki M, Sato Y, Kajita E, et al
    Total 25-hydroxyvitamin D levels predict fracture risk: results from the 15-year follow-up of the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Osteoporos Int. 2017 Feb 27. doi: 10.1007/s00198-017-3967.
    PubMed     Text format     Abstract available


  161. ROUX C, Briot K
    Imminent fracture risk.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3976.
    PubMed     Text format     Abstract available


  162. MORFELD JC, Vennedey V, Muller D, Pieper D, et al
    Patient education in osteoporosis prevention: a systematic review focusing on methodological quality of randomised controlled trials.
    Osteoporos Int. 2017 Feb 24. doi: 10.1007/s00198-017-3946.
    PubMed     Text format     Abstract available


  163. LEE SH, Hsu WT, Lai CC, Esmaily-Fard A, et al
    Erratum to: Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Feb 23. doi: 10.1007/s00198-017-3938.
    PubMed     Text format    


  164. FENG Y, Cheng G, Wang H, Chen B, et al
    The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
    Osteoporos Int. 2017 Feb 20. doi: 10.1007/s00198-017-3955.
    PubMed     Text format     Abstract available


  165. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.
    Osteoporos Int. 2017 Feb 17. doi: 10.1007/s00198-017-3940.
    PubMed     Text format     Abstract available


  166. UNGPRASERT P, Crowson CS, Matteson EL
    Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3962.
    PubMed     Text format     Abstract available


  167. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Response to: A role for thiazide diuretic therapy in preventing bone loss, fracture and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3927.
    PubMed     Text format    


  168. MORTON A
    A role for thiazide diuretic therapy in preventing bone loss, fracture, and nephrolithiasis in individuals with thalassemia and hypercalciuria?
    Osteoporos Int. 2017 Feb 13. doi: 10.1007/s00198-017-3922.
    PubMed     Text format    


  169. COSMAN F, Krege JH, Looker AC, Schousboe JT, et al
    Spine fracture prevalence in a nationally representative sample of US women and men aged >/=40 years: results from the National Health and Nutrition Examination Survey (NHANES) 2013-2014.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-017-3948.
    PubMed     Text format     Abstract available


  170. HARVEY NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, et al
    Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.
    Osteoporos Int. 2017 Feb 7. doi: 10.1007/s00198-016-3894.
    PubMed     Text format     Abstract available


  171. BALLANE G, Cauley JA, Luckey MM, El-Hajj Fuleihan G, et al
    Worldwide prevalence and incidence of osteoporotic vertebral fractures.
    Osteoporos Int. 2017 Feb 6. doi: 10.1007/s00198-017-3909.
    PubMed     Text format     Abstract available


  172. LESPESSAILLES E, Cortet B, Legrand E, Guggenbuhl P, et al
    Low-trauma fractures without osteoporosis.
    Osteoporos Int. 2017 Feb 4. doi: 10.1007/s00198-017-3921.
    PubMed     Text format     Abstract available


  173. PADRON-MONEDERO A, Lopez-Cuadrado T, Galan I, Martinez-Sanchez EV, et al
    Effect of comorbidities on the association between age and hospital mortality after fall-related hip fracture in elderly patients.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3926.
    PubMed     Text format     Abstract available


  174. MIKULA AL, Hetzel SJ, Binkley N, Anderson PA, et al
    Validity of height loss as a predictor for prevalent vertebral fractures, low bone mineral density, and vitamin D deficiency.
    Osteoporos Int. 2017 Feb 3. doi: 10.1007/s00198-017-3937.
    PubMed     Text format     Abstract available


  175. CARBONE LD, Buzkova P, Fink HA, Robbins JA, et al
    Association of DPP-4 activity with BMD, body composition, and incident hip fracture: the Cardiovascular Health Study.
    Osteoporos Int. 2017 Feb 2. doi: 10.1007/s00198-017-3916.
    PubMed     Text format     Abstract available


  176. LANDI F, Calvani R, Ortolani E, Salini S, et al
    The association between sarcopenia and functional outcomes among older patients with hip fracture undergoing in-hospital rehabilitation.
    Osteoporos Int. 2017 Feb 2. doi: 10.1007/s00198-017-3929.
    PubMed     Text format     Abstract available


    January 2017
  177. MUSCHITZ C, Kocijan R, Baierl A, Dormann R, et al
    Preceding and subsequent high- and low-trauma fracture patterns-a 13-year epidemiological study in females and males in Austria.
    Osteoporos Int. 2017 Jan 30. doi: 10.1007/s00198-017-3925.
    PubMed     Text format     Abstract available


  178. LEE SH, Hsu WT, Lai CC, Amin EF, et al
    Use of antipsychotics increases the risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-016-3881.
    PubMed     Text format     Abstract available


  179. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.
    Osteoporos Int. 2017 Jan 12. doi: 10.1007/s00198-017-3910.
    PubMed     Text format     Abstract available


  180. AYUS JC, Bellido T, Negri AL
    Hyponatremia and fractures: should hyponatremia be further studied as a potential biochemical risk factor to be included in FRAX algorithms?
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-017-3907.
    PubMed     Text format     Abstract available


  181. FUNG TT, Meyer HE, Willett WC, Feskanich D, et al
    Protein intake and risk of hip fractures in postmenopausal women and men age 50 and older.
    Osteoporos Int. 2017 Jan 10. doi: 10.1007/s00198-016-3898.
    PubMed     Text format     Abstract available


    December 2016
  182. BURGE RT, Disch DP, Gelwicks S, Zhang X, et al
    Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3888.
    PubMed     Text format     Abstract available


  183. JOHANSSON H, Siggeirsdottir K, Harvey NC, Oden A, et al
    Imminent risk of fracture after fracture.
    Osteoporos Int. 2016 Dec 27. doi: 10.1007/s00198-016-3868.
    PubMed     Text format     Abstract available


  184. ROGERS TS, Blackwell TL, Lane NE, Tranah G, et al
    Rest-activity patterns and falls and fractures in older men.
    Osteoporos Int. 2016 Dec 24. doi: 10.1007/s00198-016-3874.
    PubMed     Text format     Abstract available


  185. BARRO V, Nunez JH, Gargallo-Margarit A, Sallent A, et al
    Bilateral insufficiency hip fractures after bariatric surgery.
    Osteoporos Int. 2016 Dec 23. doi: 10.1007/s00198-016-3889.
    PubMed     Text format     Abstract available


  186. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  187. FECHTENBAUM J, Kolta S, Briot K, Roux C, et al
    Vertebral fracture assessment by dual X-ray absorptiometry.
    Osteoporos Int. 2016.
    PubMed     Text format    


  188. RUD B, Hyldstrup L
    Vertebral fracture assessment by dual X-ray absorptiometry: reply to comments by Fechtenbaum et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  189. ABDERHALDEN L, Weaver FM, Bethel M, Demirtas H, et al
    Dual-energy X-ray absorptiometry and fracture prediction in patients with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  190. CIRNIGLIARO CM, Myslinski MJ, La Fountaine MF, Kirshblum SC, et al
    Bone loss at the distal femur and proximal tibia in persons with spinal cord injury: imaging approaches, risk of fracture, and potential treatment options.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  191. KRISTENSEN PK, Thillemann TM, Pedersen AB, Soballe K, et al
    Socioeconomic inequality in clinical outcome among hip fracture patients: a nationwide cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    November 2016
  192. LAU TW, Fang C, Leung F
    The effectiveness of a multidisciplinary hip fracture care model in improving the clinical outcome and the average cost of manpower.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  193. AN T, Hao J, Sun S, Li R, et al
    Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  194. JACOB L, Kostev K
    Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  195. SAEZ-LOPEZ P, Branas F, Sanchez-Hernandez N, Alonso-Garcia N, et al
    Hip fracture registries: utility, description, and comparison.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  196. SANCHEZ A, Blanco R
    Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  197. KIM H, Baek KH, Lee SY, Ahn SH, et al
    Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  198. PEDERSEN AB, Gammelager H, Kahlert J, Sorensen HT, et al
    Impact of body mass index on risk of acute kidney injury and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  199. WU TY, Hu HY, Lin SY, Chie WC, et al
    Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  200. KRUSE C, Eiken P, Vestergaard P
    Clinical fracture risk evaluated by hierarchical agglomerative clustering.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  201. RAY R, Clement ND, Aitken SA, McQueen MM, et al
    High mortality in younger patients with major osteoporotic fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  202. CHEN FP, Shyu YC, Fu TS, Sun CC, et al
    Secular trends in incidence and recurrence rates of hip fracture: a nationwide population-based study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  203. MATHAVAN N, Tagil M, Isaksson H
    Do osteoporotic fractures constitute a greater recalcitrant challenge for skeletal regeneration? Investigating the efficacy of BMP-7 and zoledronate treatment of diaphyseal fractures in an open fracture osteoporotic rat model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  204. SHAH A, Prieto-Alhambra D, Hawley S, Delmestri A, et al
    Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    October 2016
  205. ZERBINI CA, Clark P, Mendez-Sanchez L, Pereira RM, et al
    Biologic therapies and bone loss in rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  206. SUMREIN BO, Huttunen TT, Launonen AP, Berg HE, et al
    Proximal humeral fractures in Sweden-a registry-based study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  207. MA J, McMillan HJ, Karaguzel G, Goodin C, et al
    The time to and determinants of first fractures in boys with Duchenne muscular dystrophy.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  208. ADAMS AL, Xue F, Chantra JQ, Dell RM, et al
    Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  209. BEATON DE, Vidmar M, Pitzul KB, Sujic R, et al
    Addition of a fracture risk assessment to a coordinator's role improved treatment rates within 6 months of screening in a fragility fracture screening program.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  210. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Erratum to: Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the osteoporotic fractures in men (MrOS) study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  211. BELHASSEN M, Confavreux CB, Cortet B, Lamezec L, et al
    Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  212. HARVEY NC, Biver E, Kaufman JM, Bauer J, et al
    The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Fo
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  213. HILIGSMANN M, Burlet N, Fardellone P, Al-Daghri N, et al
    Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  214. IKI M, Fujita Y, Tamaki J, Kouda K, et al
    Incident fracture associated with increased risk of mortality even after adjusting for frailty status in elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  215. SCHOUSBOE JT, Paudel ML, Taylor BC, Kats AM, et al
    Pre-fracture individual characteristics associated with high total health care costs after hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  216. YOSHIMURA M, Moriwaki K, Noto S, Takiguchi T, et al
    A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  217. MORI T, Crandall CJ, Ganz DA
    Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  218. SU Y, Leung J, Hans D, Aubry-Rozier B, et al
    Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  219. KLOP C, van Staa TP, Cooper C, Harvey NC, et al
    The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  220. WALLACE ER, Siscovick DS, Sitlani CM, Dublin S, et al
    Incident atrial fibrillation and the risk of fracture in the cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  221. SOLBAKKEN SM, Meyer HE, Stigum H, Sogaard AJ, et al
    Excess mortality following hip fracture: impact of self-perceived health, smoking, and body mass index. A NOREPOS study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  222. RUGGIERO C, Bonamassa L, Pelini L, Prioletta I, et al
    Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  223. KAMYCHEVA E, Goto T, Camargo CA Jr
    Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  224. MORIWAKI K, Noto S
    Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  225. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  226. CHEN J, Smerdely P
    Hypocalcaemia after denosumab in older people following fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  227. CHAKHTOURA M, Leslie WD, McClung M, Cheung AM, et al
    The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  228. SMALLWOOD AJ, Schapira MM, Fedders M, Neuner JM, et al
    A pilot randomized controlled trial of a decision aid with tailored fracture risk tool delivered via a patient portal.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  229. ROSENGREN BE, Bjork J, Cooper C, Abrahamsen B, et al
    Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  230. AVENELL A, Bolland MJ, Grey A, Reid IR, et al
    Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention.
    Osteoporos Int. 2016.
    PubMed     Text format    


  231. BALOGH R, Wood J, Dobranowski K, Lin E, et al
    Low-trauma fractures and bone mineral density testing in adults with and without intellectual and developmental disabilities: a population study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  232. NAKAMURA T, Fukunaga M, Nakano T, Kishimoto H, et al
    Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  233. AUBRY-ROZIER B, Fabreguet I, Iglesias K, Lamy O, et al
    Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  234. PEREIRA L, Bliuc D, Stanford P, Eisman JA, et al
    More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  235. VALA CH, Oden A, Lorentzon M, Sundh V, et al
    Increased risk of hip fracture among spouses-evidence of a homogamy effect.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    August 2016
  236. NI W, Jiang Y
    Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  237. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Time course of osteoporotic vertebral fractures by magnetic resonance imaging using a simple classification: a multicenter prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  238. DUAN X, Wang J, Jiang X
    A meta-analysis of breastfeeding and osteoporotic fracture risk in the females.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  239. SILVA BC, Rubin MR, Cusano NE, Bilezikian JP, et al
    Bone imaging in hypoparathyroidism.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  240. SU Y, Leung J, Hans D, Lamy O, et al
    The added value of trabecular bone score to FRAX(R) to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  241. TRINH A, Wong P, Brown J, Hennel S, et al
    Fractures in spina bifida from childhood to young adulthood.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  242. BUCHELE G, Becker C, Cameron ID, Auer R, et al
    Fracture risk in people with developmental disabilities: results of a large claims data analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  243. POONURU S, Findling JW, Shaker JL
    Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  244. CLARK E
    Health-related quality of life in older people with osteoporotic vertebral fractures: response to comments by Sani et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  245. SANI M, Ayubi E, Khazaei S, Mansori K, et al
    Health-related quality of life in older people with osteoporotic vertebral fractures: clinically important vs. statistically significant.
    Osteoporos Int. 2016.
    PubMed     Text format    


  246. DEDE AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, et al
    Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  247. ROTONDI NK, Beaton DE, Ilieff M, Adhihetty C, et al
    The impact of fragility fractures on work and characteristics associated with time to return to work.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  248. KIM YW, Kim JH, Yoon SH, Lee JH, et al
    Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  249. HANSEN L, Petersen KD, Eriksen SA, Gerstoft F, et al
    Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  250. LO JC, Kim S, Chandra M, Ettinger B, et al
    Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  251. KYVERNITAKIS I, Kostev K, Nassour T, Thomasius F, et al
    The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  252. FOLBERT EC, Hegeman JH, Vermeer M, Regtuijt EM, et al
    Improved 1-year mortality in elderly patients with a hip fracture following integrated orthogeriatric treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  253. MCCLOSKEY EV, Johansson H, Harvey NC, Compston J, et al
    Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  254. WOZNIAK LA, Johnson JA, McAlister FA, Beaupre LA, et al
    Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  255. GEDMINTAS L, Wright EA, Dong Y, Lehmann E, et al
    Factors associated with fractures in HIV-infected persons: which factors matter?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  256. WEAVER CM, Dawson-Hughes B, Lappe JM, Wallace TC, et al
    Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2016.
    PubMed     Text format    


  257. CHANG AJ, Ying Q, Chen XN, Wang WM, et al
    Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  258. SENAY A, Delisle J, Giroux M, Laflamme GY, et al
    The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  259. CHIANG JI, Li TC, Li CI, Liu CS, et al
    Visit-to-visit variation of fasting plasma glucose is a predictor of hip fracture in older persons with type 2 diabetes: the Taiwan Diabetes Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  260. MACHADO LG, Domiciano DS, Figueiredo CP, Caparbo VF, et al
    Visceral fat measured by DXA is associated with increased risk of non-spine fractures in nonobese elderly women: a population-based prospective cohort analysis from the Sao Paulo Ageing & Health (SPAH) Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  261. CHANG PY, Saechao FS, Lee J, Haskell SG, et al
    Prevalence and risk of fracture diagnoses in women across the adult life span: a national cross-sectional study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  262. TAKAHASHI S, Hoshino M, Takayama K, Iseki K, et al
    Predicting delayed union in osteoporotic vertebral fractures with consecutive magnetic resonance imaging in the acute phase: a multicenter cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  263. KARAYIANNIS PN, McAlinden MG
    Falling age-related incidence of hip fractures in women, but not men, in Northern Ireland: 2001-2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  264. MARQUES EA, Gudnason V, Lang T, Sigurdsson G, et al
    Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  265. SHIN YH, Gong HS, Gang DH, Shin HS, et al
    Evaluation of trabecular bone score in patients with a distal radius fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  266. CARRIERE I, Farre A, Norton J, Wyart M, et al
    Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  267. PEREIRA RM, Figueiredo CP, Cha CC, Caparbo VF, et al
    Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  268. LUCATO P, Trevisan C, Stubbs B, Zanforlini BM, et al
    Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  269. VAN DER VELDE RY, Wyers CE, Curtis EM, Geusens PP, et al
    Secular trends in fracture incidence in the UK between 1990 and 2012.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  270. BALASUBRAMANIAN A, Wade SW, Adler RA, Lin CJ, et al
    Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  271. ZHOU J, Ma X, Wang T, Zhai S, et al
    Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  272. AL-SARI UA, Tobias J, Clark E
    Health-related quality of life in older people with osteoporotic vertebral fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  273. BARZILAY JI, Buzkova P, Fink HA, Cauley JA, et al
    Systemic markers of microvascular disease and bone mineral density in older adults : The cardiovascular health study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


    May 2016
  274. ZHAO Y, Xue R, Shi N, Xue Y, et al
    Aggravation of spinal cord compromise following new osteoporotic vertebral compression fracture prevented by teriparatide in patients with surgical contraindications.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  275. LV H, Yin P, Long A, Gao Y, et al
    Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  276. SALE JE, Ashe MC, Beaton D, Bogoch E, et al
    Men's health-seeking behaviours regarding bone health after a fragility fracture: a secondary analysis of qualitative data.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  277. DE WAARD EA, Koster A, Melai T, van Geel TA, et al
    The association between glucose metabolism status, diabetes severity and a history of fractures and recent falls in participants of 50 years and older-the Maastricht Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  278. SHIRAKI M, Ueda S, Sugimoto T, Kuroda T, et al
    Treatment responses with once-weekly teriparatide therapy for osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  279. BETHEL M, Weaver FM, Bailey L, Miskevics S, et al
    Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  280. AXELSSON KF, Jacobsson R, Lund D, Lorentzon M, et al
    Effectiveness of a minimal resource fracture liaison service.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  281. SHIPMAN KE, Stammers J, Doyle A, Gittoes N, et al
    Delivering a quality-assured fracture liaison service in a UK teaching hospital-is it achievable?
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  282. LUAN L, Li R, Wang Z, Hou X, et al
    Stroke increases the risk of hip fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  283. CHUNG SM, Hyun MH, Lee E, Seo HS, et al
    Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  284. VON FRIESENDORFF M, McGuigan FE, Wizert A, Rogmark C, et al
    Hip fracture, mortality risk, and cause of death over two decades.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  285. CHAN DC, Chang CH, Lim LC, Brnabic AJ, et al
    Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  286. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Possible different roles of exercise in preventing vertebral and hip fractures: response to comments by Sugiyama et al.
    Osteoporos Int. 2016.
    PubMed     Text format    


  287. SUGIYAMA T, Watarai K, Oda T, Kim YT, et al
    Possible different roles of exercise in preventing vertebral and hip fractures.
    Osteoporos Int. 2016.
    PubMed     Text format    


  288. HOPKINS RB, Burke N, Von Keyserlingk C, Leslie WD, et al
    The current economic burden of illness of osteoporosis in Canada.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  289. CUNNINGHAM TD, Martin BC, DeShields SC, Romero CC, et al
    The impact of osteoporotic fractures compared with other health conditions in older adults living in Virginia, United States.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  290. CHOW SK, Leung KS, Qin J, Guo A, et al
    Mechanical stimulation enhanced estrogen receptor expression and callus formation in diaphyseal long bone fracture healing in ovariectomy-induced osteoporotic rats.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  291. HEILMEIER U, Cheng K, Pasco C, Parrish R, et al
    Cortical bone laminar analysis reveals increased midcortical and periosteal porosity in type 2 diabetic postmenopausal women with history of fragility fractures compared to fracture-free diabetics.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  292. MCCLUNG MR
    Cancel the denosumab holiday.
    Osteoporos Int. 2016;27:1677-82.
    PubMed     Text format    


  293. PAUPITZ JA, Lima GL, Alvarenga JC, Oliveira RM, et al
    Bone impairment assessed by HR-pQCT in juvenile-onset systemic lupus erythematosus.
    Osteoporos Int. 2016;27:1839-48.
    PubMed     Text format     Abstract available


  294. YAN L, He B, Guo H, Liu T, et al
    The prospective self-controlled study of unilateral transverse process-pedicle and bilateral puncture techniques in percutaneous kyphoplasty.
    Osteoporos Int. 2016;27:1849-55.
    PubMed     Text format     Abstract available


    April 2016
  295. WARD LM, Konji VN, Ma J
    The management of osteoporosis in children.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  296. ZHAO G, Liu X, Li F
    Balloon kyphoplasty versus percutaneous vertebroplasty for treatment of osteoporotic vertebral compression fractures (OVCFs).
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  297. BEAUDOIN C, Jean S, Bessette L, Ste-Marie LG, et al
    Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  298. SILVERMAN SL, Kupperman ES, Bukata SV
    Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  299. HA YC, Kim TY, Lee A, Lee YK, et al
    Current trends and future projections of hip fracture in South Korea using nationwide claims data.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  300. LESLIE WD, Majumdar SR, Lix LM, Josse RG, et al
    Direct comparison of FRAX and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  301. QASIM M, Farinella G, Zhang J, Li X, et al
    Patient-specific finite element estimated femur strength as a predictor of the risk of hip fracture: the effect of methodological determinants.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  302. PARK SM, Ryu J, Lee DR, Shin D, et al
    Zolpidem use and risk of fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  303. YUAN ZC, Mo H, Guan J, He JL, et al
    Risk of hip fracture following stroke, a meta-analysis of 13 cohort studies.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  304. PEDERSEN AB, Cronin Fenton D, Norgaard M, Kristensen NR, et al
    Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  305. THORNE K, Johansen A, Akbari A, Williams JG, et al
    The impact of social deprivation on mortality following hip fracture in England and Wales: a record linkage study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  306. WALLACE IJ, Botigue LR, Lin M, Smaers JB, et al
    Worldwide variation in hip fracture incidence weakly aligns with genetic divergence between populations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  307. CHOI HJ, Park C, Lee YK, Ha YC, et al
    Risk of fractures and diabetes medications: a nationwide cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  308. HILIGSMANN M, Ronda G, van der Weijden T, Boonen A, et al
    The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  309. HEANEY RP
    Achieving the protection of high peak bone mass.
    Osteoporos Int. 2016;27:1279-80.
    PubMed     Text format    


    March 2016
  310. FROST SA, Nguyen TV
    Uncertain effects of calcium and vitamin D supplementation on fracture risk reduction.
    Osteoporos Int. 2016.
    PubMed     Text format    


  311. BAE SJ, Lee SH, Ahn SH, Kim HM, et al
    The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  312. EVSTIGNEEVA L, Lesnyak O, Bultink IE, Lems WF, et al
    Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  313. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Erratum to: Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format    


  314. YIN P, Lv H, Zhang L, Long A, et al
    Combination of red cell distribution width and American Society of Anesthesiologists score for hip fracture mortality prediction.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  315. ROUX JP, Belghali S, Wegrzyn J, Rendu ES, et al
    Vertebral body morphology is associated with incident lumbar vertebral fracture in postmenopausal women. The OFELY study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  316. NAYLOR KL, Lix LM, Hans D, Garg AX, et al
    Trabecular bone score in kidney transplant recipients.
    Osteoporos Int. 2016;27:1115-21.
    PubMed     Text format     Abstract available


  317. MAMAN E, Borderie D, Roux C, Briot K, et al
    Absence of recognition of low alkaline phosphatase level in a tertiary care hospital.
    Osteoporos Int. 2016;27:1251-4.
    PubMed     Text format     Abstract available


    February 2016
  318. PERRY BA, Archer KR, Song Y, Ma Y, et al
    Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  319. HOPKINS SJ, Toms AD, Brown M, Welsman JR, et al
    A study investigating short- and medium-term effects on function, bone mineral density and lean tissue mass post-total knee replacement in a Caucasian female post-menopausal population: implications for hip fracture risk.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  320. BYNUM JP, Bell JE, Cantu RV, Wang Q, et al
    Second fractures among older adults in the year following hip, shoulder, or wrist fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  321. JURISSON M, Pisarev H, Kanis J, Borgstrom F, et al
    Quality of life, resource use, and costs related to hip fracture in Estonia.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  322. EL-HAJ M, Gurt I, Cohen-Kfir E, Dixit V, et al
    Reduced Sirtuin1 expression at the femoral neck in women who sustained an osteoporotic hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  323. SOGAARD AJ, Holvik K, Meyer HE, Tell GS, et al
    Continued decline in hip fracture incidence in Norway: a NOREPOS study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  324. DELESKOG L, Laursen NO, Nielsen BR, Schwarz P, et al
    Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  325. SUGIYAMA T, Watarai K, Oda T, Kim YT, et al
    Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?
    Osteoporos Int. 2016.
    PubMed     Text format    


  326. NORIEGA DC, Ramajo RH, Lite IS, Toribio B, et al
    Safety and clinical performance of kyphoplasty and SpineJack procedures in the treatment of osteoporotic vertebral compression fractures: a pilot, monocentric, investigator-initiated study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  327. WEAVER CM, Gordon CM, Janz KF, Kalkwarf HJ, et al
    The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  328. MEYER HE, Willett WC, Flint AJ, Feskanich D, et al
    Abdominal obesity and hip fracture: results from the Nurses' Health Study and the Health Professionals Follow-up Study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  329. HAGEN G, Wisloff T, Kristiansen IS
    The predicted lifetime costs and health consequences of calcium and vitamin D supplementation for fracture prevention-the impact of cardiovascular effects.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  330. DRIESSEN JH, Hansen L, Eriksen SA, van Onzenoort HA, et al
    The epidemiology of fractures in Denmark in 2011.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  331. UZOIGWE OF
    Proton pump inhibitors and fracture: do they do what it says on the tin?
    Osteoporos Int. 2016.
    PubMed     Text format    


    January 2016
  332. BURGERS PT, Hoogendoorn M, Van Woensel EA, Poolman RW, et al
    Total medical costs of treating femoral neck fracture patients with hemi- or total hip arthroplasty: a cost analysis of a multicenter prospective study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  333. SI L, Winzenberg TM, Chen M, Jiang Q, et al
    Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  334. PAPAIOANNOU A, Kennedy CC, Ioannidis G, Cameron C, et al
    Comparative trends in incident fracture rates for all long-term care and community-dwelling seniors in Ontario, Canada, 2002-2012.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  335. PIOLI G, Lauretani F, Pellicciotti F, Pignedoli P, et al
    Modifiable and non-modifiable risk factors affecting walking recovery after hip fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  336. PEDERSEN AB, Baggesen LM, Ehrenstein V, Pedersen L, et al
    Perceived stress and risk of any osteoporotic fracture.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  337. KATZMAN WB, Vittinghoff E, Kado DM, Lane NE, et al
    Thoracic kyphosis and rate of incident vertebral fractures: the Fracture Intervention Trial.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  338. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  339. LEE JH, Lee YK, Oh SH, Ahn J, et al
    A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  340. DREW S, Judge A, Cooper C, Javaid MK, et al
    Secondary prevention of fractures after hip fracture: a qualitative study of effective service delivery.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  341. WANG X, Yan S, Liu C, Xu Y, et al
    Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  342. ORIMO H, Yaegashi Y, Hosoi T, Fukushima Y, et al
    Hip fracture incidence in Japan: Estimates of new patients in 2012 and 25-year trends.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  343. BLIEMEL C, Sielski R, Doering B, Dodel R, et al
    Pre-fracture quality of life predicts 1-year survival in elderly patients with hip fracture-development of a new scoring system.
    Osteoporos Int. 2016.
    PubMed     Text format     Abstract available


  344. LESLIE WD, Schousboe JT, Lix LM
    Towards better use of the net reclassification improvement (NRI) index.
    Osteoporos Int. 2016;27:411-2.
    PubMed     Text format    


  345. LEIB ES, Winzenrieth R
    Bone status in glucocorticoid-treated men and women.
    Osteoporos Int. 2016;27:39-48.
    PubMed     Text format     Abstract available


  346. NEUMANN T, Lodes S, Kastner B, Lehmann T, et al
    Trabecular bone score in type 1 diabetes--a cross-sectional study.
    Osteoporos Int. 2016;27:127-33.
    PubMed     Text format     Abstract available


  347. OTAIFY GA, Aglan MS, Ibrahim MM, Elnashar M, et al
    Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Osteoporos Int. 2016;27:81-92.
    PubMed     Text format     Abstract available


  348. HARVEY NC, Johansson H, Oden A, Karlsson MK, et al
    FRAX predicts incident falls in elderly men: findings from MrOs Sweden.
    Osteoporos Int. 2016;27:267-74.
    PubMed     Text format     Abstract available


    December 2015
  349. POPP AW, Zysset PK, Lippuner K
    Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  350. AMICHE MA, Albaum JM, Tadrous M, Pechlivanoglou P, et al
    Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  351. ANASTASILAKIS AD, Makras P
    Multiple clinical vertebral fractures following denosumab discontinuation.
    Osteoporos Int. 2015.
    PubMed     Text format    


  352. SILVERMAN SL, Adachi JD, Dennison E
    Bisphosphonate drug holidays: we reap what we sow.
    Osteoporos Int. 2015.
    PubMed     Text format    


  353. KRUSE C, Eiken P, Vestergaard P
    Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  354. SVENSSON HK, Olofsson EH, Karlsson J, Hansson T, et al
    A painful, never ending story: older women's experiences of living with an osteoporotic vertebral compression fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  355. BETHEL M, Buzkova P, Fink HA, Robbins JA, et al
    Soluble CD14 and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  356. NAKAYAMA A, Major G, Holliday E, Attia J, et al
    Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  357. XU LH, Adams-Huet B, Poindexter JR, Maalouf NM, et al
    Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  358. BOURS S, de Vries F, van den Bergh JP, Lalmohamed A, et al
    Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  359. RUDANG R, Zoulakis M, Sundh D, Brisby H, et al
    Bone material strength is associated with areal BMD but not with prevalent fractures in older women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  360. FINNES TE, Lofthus CM, Meyer HE, Sogaard AJ, et al
    A combination of low serum concentrations of vitamins K and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    November 2015
  361. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton pump inhibitors and fracture risk: response to comments.
    Osteoporos Int. 2015.
    PubMed     Text format    


  362. SENAY A, Delisle J, Raynauld JP, Morin SN, et al
    Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  363. MARAVIC M, Ostertag A, Urena P, Cohen-Solal M, et al
    Dementia is a major risk factor for hip fractures in patients with chronic kidney disease.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  364. BROZEK W, Reichardt B, Zwerina J, Dimai HP, et al
    Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  365. MADSEN CM, Jantzen C, Lauritzen JB, Abrahamsen B, et al
    Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  366. AVILA ML, Pullenayegum E, Williams S, Shammas A, et al
    Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  367. CLARK EM, Gooberman-Hill R, Peters TJ
    Using self-reports of pain and other variables to distinguish between older women with back pain due to vertebral fractures and those with back pain due to degenerative changes.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  368. UZOIGWE CE
    The real enemy is fragility fracture, not osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format    


  369. MCCLOSKEY E
    A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base.
    Osteoporos Int. 2015.
    PubMed     Text format    


  370. FARSINEJAD-MARJ M, Saneei P, Esmaillzadeh A
    Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  371. MURRAY JC, Audet MC, Bedard M, Michou L, et al
    Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  372. BEALL DP, Feldman RG, Gordon ML, Gruber BL, et al
    Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  373. SUGIYAMA T, Torio T, Miyajima T, Kim YT, et al
    Calcium, proton pump inhibitors, and fracture risk.
    Osteoporos Int. 2015.
    PubMed     Text format    


  374. RUD B, Vestergaard A, Hyldstrup L
    Accuracy of densitometric vertebral fracture assessment when performed by DXA technicians-a cross-sectional, multiobserver study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  375. CHEN F, Dai Z, Kang Y, Lv G, et al
    Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  376. WIKLUND R, Toots A, Conradsson M, Olofsson B, et al
    Risk factors for hip fracture in very old people: a population-based study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  377. JACOB L, Dreher M, Kostev K, Hadji P, et al
    Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  378. SATO H, Kondo N, Wada Y, Nakatsue T, et al
    The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  379. WEAVER CM, Alexander DD, Boushey CJ, Dawson-Hughes B, et al
    Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  380. DARUWALLA ZJ, Huq SS, Wong KL, Nee PY, et al
    Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  381. AUBRY-ROZIER B, Gonzalez-Rodriguez E, Stoll D, Lamy O, et al
    Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  382. MEMETOGLU OG, Ozkan FU, Boy NS, Aktas I, et al
    Sacroiliitis or insufficiency fracture?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  383. NAZARZADEH M, Bidel Z, Sanjari Moghaddam A
    Meta-analysis of diabetes mellitus and risk of hip fractures: small-study effect.
    Osteoporos Int. 2015.
    PubMed     Text format    


  384. SELGA J, Nunez JH, Minguell J, Lalanza M, et al
    Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  385. HOLM JP, Amar AO, Hyldstrup L, Jensen JE, et al
    Hyponatremia, a risk factor for osteoporosis and fractures in women.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  386. SUGIYAMA T, Kim YT, Oda H
    Both falling and bone fragility should be targeted to prevent hip fracture in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format    


  387. EBINA K, Noguchi T, Hirao M, Hashimoto J, et al
    Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  388. ZHOU B, Huang Y, Li H, Sun W, et al
    Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  389. RAMCHAND SK, Chiang CY, Zebaze RM, Seeman E, et al
    Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  390. FINK HA, Litwack-Harrison S, Taylor BC, Bauer DC, et al
    Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  391. WANG Q, Huang Q, Zeng Y, Liang JJ, et al
    Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  392. HOLLOWAY KL, Henry MJ, Brennan-Olsen SL, Bucki-Smith G, et al
    Non-hip and non-vertebral fractures: the neglected fracture sites.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    September 2015
  393. HEGDE V, Jo JE, Andreopoulou P, Lane JM, et al
    Effect of osteoporosis medications on fracture healing.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  394. LEE SJ, Binkley N, Lubner MG, Bruce RJ, et al
    Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  395. MUSEYKO O, Bousson V, Adams J, Laredo J-, et al
    QCT of the proximal femur-which parameters should be measured to discriminate hip fracture?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  396. BLACKBURN J, Locher JL, Morrisey MA, Becker DJ, et al
    The effects of state-level expenditures for home- and community-based services on the risk of becoming a long-stay nursing home resident after hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  397. ETHGEN O, Hiligsmann M, Burlet N, Reginster JY, et al
    Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  398. HWANG IR, Choi YK, Lee WK, Kim JG, et al
    Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  399. THINGSTAD P, Taraldsen K, Saltvedt I, Sletvold O, et al
    The long-term effect of comprehensive geriatric care on gait after hip fracture: the Trondheim Hip Fracture Trial-a randomised controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  400. LUO Y
    A biomechanical sorting of clinical risk factors affecting osteoporotic hip fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  401. FRITZ J, Coster ME, Nilsson JA, Rosengren BE, et al
    The associations of physical activity with fracture risk-a 7-year prospective controlled intervention study in 3534 children.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  402. BONE HG, Dempster DW, Eisman JA, Greenspan SL, et al
    Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.
    Osteoporos Int. 2015.
    PubMed     Text format    


  403. LANDEIRO F, Leal J, Gray AM
    The impact of social isolation on delayed hospital discharges of older hip fracture patients and associated costs.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  404. CARBONE S, Papalia M
    The amount of impaction and loss of reduction in osteoporotic proximal humeral fractures after surgical fixation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    August 2015
  405. LOPEZ-DE-ANDRES A, Jimenez-Garcia R, Jimenez-Trujillo I, Hernandez-Barrera V, et al
    Incidence, surgical procedures, and outcomes of hip fracture among elderly type 2 diabetic and non-diabetic patients in Spain (2004-2013).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  406. THORIN MH, Wihlborg A, Akesson K, Gerdhem P, et al
    Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  407. SCAGLIONE M, Fabbri L, Casella F, Guido G, et al
    Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  408. EDWARDS BJ, Gradishar WJ, Smith ME, Pacheco JA, et al
    Elevated incidence of fractures in women with invasive breast cancer.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  409. MOON RJ, Lim A, Farmer M, Segaran A, et al
    Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  410. LEAL J, Gray AM, Prieto-Alhambra D, Arden NK, et al
    Impact of hip fracture on hospital care costs: a population-based study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  411. HOLZMUELLER CG, Karp S, Zeldow D, Lee DB, et al
    Development of a cloud-based application for the Fracture Liaison Service model of care.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  412. KHOO BC, Lewis JR, Brown K, Prince RL, et al
    Evaluation of a simplified hip structure analysis method for the prediction of incident hip fracture events.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  413. YONG JH, Masucci L, Hoch JS, Sujic R, et al
    Cost-effectiveness of a fracture liaison service-a real-world evaluation after 6 years of service provision.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  414. FECHTENBAUM J, Etcheto A, Kolta S, Feydy A, et al
    Sagittal balance of the spine in patients with osteoporotic vertebral fractures.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  415. BARZILAY JI, Buzkova P, Kizer JR, Djousse L, et al
    Fibrosis markers, hip fracture risk, and bone density in older adults.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  416. TIAN M, Gong X, Rath S, Wei J, et al
    Management of hip fractures in older people in Beijing: a retrospective audit and comparison with evidence-based guidelines and practice in the UK.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  417. FAN Y, Wei F, Lang Y, Liu Y, et al
    Diabetes mellitus and risk of hip fractures: a meta-analysis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  418. ORIVE M, Anton-Ladislao A, Garcia-Gutierrez S, Las Hayas C, et al
    Prospective study of predictive factors of changes in pain and hip function after hip fracture among the elderly.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  419. LESLIE WD, Brennan-Olsen SL, Morin SN, Lix LM, et al
    Fracture prediction from repeat BMD measurements in clinical practice.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  420. CHANG CY, Tang CH, Chen KC, Huang KC, et al
    The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  421. YAN Z, Huang H, Li J, Wang J, et al
    Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  422. PLUSKIEWICZ W, Adamczyk P, Czekajlo A, Grzeszczak W, et al
    Erratum to: High fracture probability predicts fractures in a 4-year follow-up in women from the RAC-OST-POL study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  423. HA KY, Park KS, Kim SI, Kim YH, et al
    Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  424. PAPAPOULOS S, Lippuner K, Roux C, Lin CJ, et al
    The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  425. ZHUKOUSKAYA VV, Eller-Vainicher C, Gaudio A, Privitera F, et al
    Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format    


  426. LING Y, Gao X, Lin H, Ma H, et al
    A common polymorphism rs1800247 in osteocalcin gene was associated with serum osteocalcin levels, bone mineral density, and fracture: the Shanghai Changfeng Study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  427. PLUSKIEWICZ W, Adamczyk P, Czekajlo A, Grzeszczak W, et al
    High fracture probability predicts fractures in a 4-year follow-up in women from the RAC-OST-POL study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  428. DAVEY T, Lanham-New SA, Shaw AM, Hale B, et al
    Low serum 25-hydroxyvitamin D is associated with increased risk of stress fracture during Royal Marine recruit training.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  429. ZHUKOUSKAYA VV, Vainicher CE, Gaudio A, Privitera F, et al
    The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  430. ALBAUM JM, Levesque LE, Gershon AS, Liu G, et al
    Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  431. COMPSTON J
    Overdiagnosis of osteoporosis: fact or fallacy?
    Osteoporos Int. 2015.
    PubMed     Text format    


  432. WANG CY, Fu SH, Wang CL, Chen PJ, et al
    Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


    June 2015
  433. SALE JE, Gignac MA, Hawker G, Beaton D, et al
    Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  434. AMOUZOUGAN A, Deygat A, Trombert B, Constant E, et al
    Spectacular improvement in vitamin D status in elderly osteoporotic women: 8-year analysis of an osteoporotic population treated in a dedicated fracture liaison service.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  435. HERNANDEZ I, Pinera A
    Incidence of fracture events with teriparatide: role of study design.
    Osteoporos Int. 2015.
    PubMed     Text format    


  436. HARVEY NC, Kanis JA, Oden A, Burge RT, et al
    FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  437. HARVEY NC, Kanis JA, Oden A, Nakamura T, et al
    Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  438. JAVAID MK, Kyer C, Mitchell PJ, Chana J, et al
    Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture(R) Best Practice Framework tool.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  439. FERRARI S, Adachi JD, Lippuner K, Zapalowski C, et al
    Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  440. BRIOT K, Fechtenbaum J, Etcheto A, Kolta S, et al
    Diagnosis of vertebral fractures using a low-dose biplanar imaging system.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  441. NARANJO A, Ojeda-Bruno S, Bilbao-Cantarero A, Quevedo-Abeledo JC, et al
    Two-year adherence to treatment and associated factors in a fracture liaison service in Spain.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  442. GUO Z, Yang J, Zheng Y, Wang Y, et al
    Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study.
    Osteoporos Int. 2015.
    PubMed     Text format    


  443. HASHEM J, Krochak R, Culbertson MD, Mileto C, et al
    Atypical femur fractures in a patient with pycnodysostosis: a case report.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  444. YAN Y, Zou T, Xu R
    Reply to "Thoracolumbar fascia injury associated with residual back pain after percutaneous vertebroplasty: a compelling study".
    Osteoporos Int. 2015.
    PubMed     Text format    


    May 2015
  445. ODEN A, McCloskey EV, Kanis JA, Harvey NC, et al
    Burden of high fracture probability worldwide: secular increases 2010-2040.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  446. HADJI P, Papaioannou N, Gielen E, Feudjo Tepie M, et al
    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  447. CROCKETT K, Arnold CM, Farthing JP, Chilibeck PD, et al
    Bone strength and muscle properties in postmenopausal women with and without a recent distal radius fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  448. NAKAMURA T, Ito M, Hashimoto J, Shinomiya K, et al
    Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  449. WU CT, Yang YH, Chen PC, Chen MF, et al
    Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  450. MARQUES A, Lourenco O, da Silva JA
    The burden of osteoporotic hip fractures in Portugal: costs, health related quality of life and mortality.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  451. FREEDBERG DE, Haynes K, Denburg MR, Zemel BS, et al
    Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  452. SABHARWAL S, Wilson H
    Orthogeriatrics in the management of frail older patients with a fragility fracture.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  453. TSUKUTANI Y, Hagino H, Ito Y, Nagashima H, et al
    Epidemiology of fragility fractures in Sakaiminato, Japan: incidence, secular trends, and prognosis.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  454. WANG O, Hu Y, Gong S, Xue Q, et al
    A survey of outcomes and management of patients post fragility fractures in China.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  455. KEMMLER W, Bebenek M, Kohl M, von Stengel S, et al
    Exercise and fractures in postmenopausal women. Final results of the controlled Erlangen Fitness and Osteoporosis Prevention Study (EFOPS).
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  456. KLOP C, Gibson-Smith D, Elders PJ, Welsing PM, et al
    Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  457. YOUN JC, Lee SJ, Lee HS, Oh J, et al
    Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  458. MIYAKOSHI N, Hongo M, Kobayashi T, Abe T, et al
    Improvement of spinal alignment and quality of life after corrective surgery for spinal kyphosis in patients with osteoporosis: a comparative study with non-operated patients.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  459. CIZMIC AD, Heilmann RM, Milchak JL, Riggs CS, et al
    Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  460. CHEN L, Wang G, Zheng F, Zhao H, et al
    Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  461. KOVACS CS, Ralston SH
    Presentation and management of osteoporosis presenting in association with pregnancy or lactation.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  462. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Cortisol and the muscle-bone axis: response to comments by Molfino et al.
    Osteoporos Int. 2015;26:1661-2.
    PubMed     Text format    


    April 2015
  463. MOON RJ, Harvey NC, Davies JH, Cooper C, et al
    Vitamin D and bone development.
    Osteoporos Int. 2015;26:1449-51.
    PubMed     Text format    


  464. SUGIYAMA T, Yoshioka H, Sakaguchi K, Kim YT, et al
    An evidence-based perspective on vitamin D and the growing skeleton.
    Osteoporos Int. 2015;26:1447-8.
    PubMed     Text format    


  465. STOLLENWERK B, Bartmus T, Klug F, Stock S, et al
    Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.
    Osteoporos Int. 2015;26:1367-79.
    PubMed     Text format     Abstract available


  466. BORGSTROM F, Beall DP, Berven S, Boonen S, et al
    Health economic aspects of vertebral augmentation procedures.
    Osteoporos Int. 2015;26:1239-49.
    PubMed     Text format     Abstract available


    March 2015
  467. CLAESSON A, Toth-Pal E, Piispanen P, Salminen H, et al
    District nurses' perceptions of osteoporosis management: a qualitative study.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  468. HANDS B, Chivers P, McIntyre F, Bervenotti FC, et al
    Peripheral quantitative computed tomography (pQCT) reveals low bone mineral density in adolescents with motor difficulties.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  469. MAKRAS P, Athanasakis K, Boubouchairopoulou N, Rizou S, et al
    Cost-effective osteoporosis treatment thresholds in Greece.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  470. DAMJI AN, Bies K, Alibhai SM, Jones JM, et al
    Bone health management in men undergoing ADT: examining enablers and barriers to care.
    Osteoporos Int. 2015;26:951-9.
    PubMed     Text format     Abstract available


  471. RUSSELL M, Clapperton A, Vu T, Day L, et al
    Trends in fall-related hospitalisations in older people living in aged care facilities.
    Osteoporos Int. 2015;26:1219-24.
    PubMed     Text format     Abstract available


    January 2015
  472. BANSAL S, Pecina JL, Merry SP, Kennel KA, et al
    US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  473. MCCLUNG MR
    Bisphosphonate therapy: how long is long enough?
    Osteoporos Int. 2015.
    PubMed     Text format    


  474. MACHADO KL, Domiciano DS, Machado LG, Lopes JB, et al
    Persistent hypovitaminosis D and loss of hip bone mineral density over time as additional risk factors for recurrent falls in a population-based prospective cohort of elderly persons living in the community. The Sao Paulo Ageing & Health (SPAH) St
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  475. SI L, Winzenberg TM, Jiang Q, Palmer AJ, et al
    Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Osteoporos Int. 2015.
    PubMed     Text format     Abstract available


  476. STUCKEY BG, Sallie R
    Alendronate-induced unmasking or deterioration of coeliac disease: a case series.
    Osteoporos Int. 2015;26:411-4.
    PubMed     Text format    


  477. ZHU TY, Griffith JF, Qin L, Hung VW, et al
    Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.
    Osteoporos Int. 2015;26:261-72.
    PubMed     Text format     Abstract available


  478. CHOI WJ, Cripton PA, Robinovitch SN
    Effects of hip abductor muscle forces and knee boundary conditions on femoral neck stresses during simulated falls.
    Osteoporos Int. 2015;26:291-301.
    PubMed     Text format     Abstract available


    December 2014
  479. HUANG ZB, Wan SL, Lu YJ, Ning L, et al
    Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  480. YAN Y, Xu R, Zou T
    Is thoracolumbar fascia injury the cause of residual back pain after percutaneous vertebroplasty? A prospective cohort study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  481. OHTA H, Solanki J
    Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    November 2014
  482. OLENGINSKI TP, Maloney-Saxon G, Matzko CK, Mackiewicz K, et al
    High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized, programmatic approach.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    October 2014
  483. SHELTAWY AA, Criseno S, Gittoes NJ, Crowley RK, et al
    Fear of medication side effects is a barrier to optimal osteoporosis care.
    Osteoporos Int. 2014.
    PubMed     Text format    


  484. STROM O, Landfeldt E, Garellick G
    Residual effect after oral bisphosphonate treatment and healthy adherer effects-the Swedish adherence register analysis (SARA).
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    September 2014
  485. SILVERMAN SL, Siris E, Kendler DL, Belazi D, et al
    Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  486. KANIS JA, McCloskey E, Branco J, Brandi ML, et al
    Goal-directed treatment of osteoporosis in Europe.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  487. MOLFINO A, Aversa Z, Muscaritoli M
    Cortisol and the muscle-bone axis.
    Osteoporos Int. 2014;25:2331-2.
    PubMed     Text format    


  488. DAVIE MW
    Identifying coeliac disease in DXA referrals.
    Osteoporos Int. 2014;25:2329.
    PubMed     Text format    


    August 2014
  489. IKI M, Tamaki J, Sato Y, Winzenrieth R, et al
    Age-related normative values of trabecular bone score (TBS) for Japanese women: the Japanese Population-based Osteoporosis (JPOS) study.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  490. LU Y, Krause M, Bishop N, Sellenschloh K, et al
    The role of patient-mode high-resolution peripheral quantitative computed tomography indices in the prediction of failure strength of the elderly women's thoracic vertebral body.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  491. COSMAN F, de Beur SJ, LeBoff MS, Lewiecki EM, et al
    Clinician's Guide to Prevention and Treatment of Osteoporosis.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    July 2014
  492. OH JH, Song BW, Kim SH, Choi JA, et al
    The measurement of bone mineral density of bilateral proximal humeri using DXA in patients with unilateral rotator cuff tear.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  493. RIZZOLI R, Branco J, Brandi ML, Boonen S, et al
    Management of osteoporosis of the oldest old.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


  494. KYVERNITAKIS I, Kostev K, Kurth A, Albert US, et al
    Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    June 2014
  495. CUNNINGHAM TD, Di Pace BS, Ullal J
    Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data.
    Osteoporos Int. 2014.
    PubMed     Text format     Abstract available


    March 2014
  496. PRENTICE RL, Jackson RD, Pettinger M, Rossouw JE, et al
    Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane.
    Osteoporos Int. 2014;25:1195.
    PubMed     Text format    


  497. NEUPANE S
    Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study.
    Osteoporos Int. 2014;25:1193.
    PubMed     Text format    


    February 2014
  498. SCILLITANI A, Mazziotti G, Di Somma C, Moretti S, et al
    Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?
    Osteoporos Int. 2014;25:441-6.
    PubMed     Text format     Abstract available


  499. HAGE MP, El-Hajj Fuleihan G
    Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass.
    Osteoporos Int. 2014;25:423-39.
    PubMed     Text format     Abstract available


  500. PHAN V, Blydt-Hansen T, Feber J, Alos N, et al
    Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.
    Osteoporos Int. 2014;25:627-37.
    PubMed     Text format     Abstract available


  501. CHEN CK, Chang HT, Chou HP, Lee MH, et al
    Alendronate and risk of lower limb ischemic vascular events: a population-based cohort study.
    Osteoporos Int. 2014;25:673-80.
    PubMed     Text format     Abstract available


    August 2013
  502. NAEGELI AN , Nixon A, Burge R, Gold DT, et al
    Development of the osteoporosis assessment questionnaire-physical function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function.
    Osteoporos Int. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Fractures is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: